CRVAF Financials: Curvebeam AI Ltd AI Analysis

Home

Stock

CRVAF

Financials

CRVAF Financial

Curvebeam AI Ltd

$0.05

At close: Mar 25, 16:00:00 GMT-4

$0.05

Post-market: Mar 25, 18:58:49 GMT-4

Overview Forecast Earnings Dividends Financials

Income

Balance sheet

Cash flow

Annual

Quarterly

CRVAF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	06/30/2025	06/30/2024	06/30/2023	06/30/2022	06/30/2021
Revenue	12	12	6	8	1	0
Revenue Growth (YoY)	71%	100%	-25%	700%	--	--
Cost of Revenue	7	6	3	3	0	0
Gross Profit	5	5	3	4	1	0
Selling, General & Admin	19	20	22	21	7	3
Research & Development	0	0	0	0	0	0
Operating Expenses	20	22	24	42	7	3
Other Non Operating Income (Expenses)	--	--	--	--	0	--
Pretax Income	-16	-16	-23	-52	-8	-2
Income Tax Expense	--	0	0	0	--	--
Net Income	-16	-16	-23	-52	-8	-2
Net Income Growth	-16%	-30%	-56%	550%	300%	--
Shares Outstanding (Diluted)	425.19	375	294.42	331.3	331.3	331.3
Shares Change (YoY)	17%	27%	-11%	0%	0%	--
EPS (Diluted)	-0.03	-0.04	-0.07	-0.15	-0.02	0
EPS Growth	-38%	-43%	-50%	509%	204%	--
Free Cash Flow	-10	-11	-22	-22	-8	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	41.66%	41.66%	50%	50%	100%	0%
Operating Margin	-125%	-133.33%	-350%	-475%	-500%	0%
Profit Margin	-133.33%	-133.33%	-383.33%	-650%	-800%	0%
Free Cash Flow Margin	-83.33%	-91.66%	-366.66%	-275%	-800%	0%
EBITDA	-12	-14	-19	-37	-5	-2
EBITDA Margin	-100%	-116.66%	-316.66%	-462.5%	-500%	0%
D&A For EBITDA	3	2	2	1	0	0
EBIT	-15	-16	-21	-38	-5	-2
EBIT Margin	-125%	-133.33%	-350%	-475%	-500%	0%
Effective Tax Rate	--	0%	0%	0%	--	--

Follow-Up Questions

What are Curvebeam AI Ltd's key financial statements?



According to the latest financial statement (Form-10K), Curvebeam AI Ltd has a total asset of $60, Net loss of $-16

What are the key financial ratios for CRVAF?



Curvebeam AI Ltd's Current ratio is 2.4, has a Net margin is -133.33, sales per share of $0.03.

How is Curvebeam AI Ltd's revenue broken down by segment or geography?



Curvebeam AI Ltd largest revenue segment is Specialised Medical Imaging (Computed Tomography) Equipment, at a revenue of 4,498,584 in the most earnings release.For geography, North America is the primary market for Curvebeam AI Ltd, at a revenue of 5,019,472.

Is Curvebeam AI Ltd profitable?



no, according to the latest financial statements, Curvebeam AI Ltd has a net loss of $-16

Does Curvebeam AI Ltd have any liabilities?



yes, Curvebeam AI Ltd has liability of 25

How many outstanding shares for Curvebeam AI Ltd?



Curvebeam AI Ltd has a total outstanding shares of 387.91

Key Stats

Prev.Close

$0.054

Open

Day's Range

52 week range

$0.054 - $0.054

Volume

Avg.Volume

Dividend yield

EPS (TTM)

-0.03

Market Cap

$25.7M

What is CRVAF?

CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Its products include HiRise, LineUp, PedCAT Premium, pedCAT, InReach, OssView, CubeVue Software, Autometrics, 3D Measurement Tools and Cloud. HiRise is a bilateral, weight-bearing CT imaging of the entire lower extremities including hips/pelvis and distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach is a point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities. InReach HR-pQCT is a high-resolution peripheral quantitative CT (HR-pQCT) imaging designed for the point-of-care. OssView is a bone fragility software that analyzes HR-pQCT images at the distal radius to measure the bone microarchitecture.



Features

AI Copilot for Stock & Crypto

Resources